Provided by Tiger Trade Technology Pte. Ltd.

HBM HOLDINGS-B

12.640
0.000
Volume:3.00K
Turnover:37.92K
Market Cap:11.00B
PE:3.50K
High:12.640
Open:12.640
Low:12.640
Close:12.640
52wk High:17.980
52wk Low:5.320
Shares:870.00M
HK Float Shares:870.00M
Volume Ratio:- -
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.004
ROE:36.59%
ROA:13.49%
PB:4.97
PE(LYR):3,495.58
PS:12.13

Loading ...

HBM Holdings Signs Evaluation and License Agreement with Umoja Biopharma

Reuters
·
Nov 05, 2025

HBM Holdings-B (02142) Enters Evaluation and License Agreement with Umoja Biopharma

Stock News
·
Nov 05, 2025

Hbm Holdings - Nona Biosciences Eligible for Upfront and Milestone Payments

THOMSON REUTERS
·
Nov 05, 2025

Hbm Holdings - Enters Evaluation and License Agreement With Umoja Biopharma

THOMSON REUTERS
·
Nov 05, 2025

Hbm Holdings - Nona Biosciences and Umoja to Create in Vivo CAR-T Products

THOMSON REUTERS
·
Nov 05, 2025

HBM Holdings (02142) Announces Share Repurchase and New Share Issuance

Bulletin Express
·
Nov 04, 2025

HBM HOLDINGS-B (02142) Repurchases 200,000 Shares for HK$2.5849 Million on November 4

Stock News
·
Nov 04, 2025

HK Stock Buyback Summary | October 31

Stock News
·
Oct 31, 2025

HBM Holdings (02142) Announces Changes in Issued Shares and Treasury Shares

Bulletin Express
·
Oct 30, 2025

HBM HOLDINGS-B (02142) Repurchases 100,000 Shares for HK$1.33 Million on October 30

Stock News
·
Oct 30, 2025

HBM Holdings Files HKEX Disclosure on Repurchase of 100,000 Shares for HKD 1,333,250

Reuters
·
Oct 30, 2025

HBM HOLDINGS-B (02142) Rises Over 4% After Launching First Fully Human HCAb Generation Model to Accelerate Next-Gen Therapies

Stock News
·
Oct 30, 2025

Harbour BioMed Unveils AI-Driven Platform for Fully Human Antibody Discovery

Reuters
·
Oct 28, 2025

Hong Kong Stock Movement | HBM HOLDINGS-B (02142) Surges Over 6% as Partnership with AstraZeneca Deepens; AI Laboratory Platform Set to Launch

Stock News
·
Oct 27, 2025

HBM (02142) Announces Next Day Disclosure Return Highlighting Share Repurchases and New Issuance

Bulletin Express
·
Oct 23, 2025

Hong Kong Stock Buyback Statistics | October 23

Stock News
·
Oct 23, 2025

Harbour BioMed Reports Positive Phase II Results for HBM4003 and Tislelizumab in MSS Metastatic Colorectal Cancer

Reuters
·
Oct 23, 2025

Harbour Biomed Announces Positive Phase Ii Results for Hbm4003 and Tislelizumab Combination in Mss Mcrc

THOMSON REUTERS
·
Oct 23, 2025

HBM Holdings (02142) Announces Changes in Issued Shares and Share Repurchase Details

Bulletin Express
·
Oct 22, 2025

HBM Holdings Repurchases 50,000 Shares at HK$12.98 Each in HKEX Filing

Reuters
·
Oct 22, 2025